News on NAGS from BioPortfolio.com http://www.BioPortfolio.com Consolidated NAGS news from BioPortfolio.com Wed, 10 Feb 2010 03:05:28 GMT en Snow cancellations, closings; no HRT bus service todayhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989281&HITNO=0&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989281&THISHREF=http://c.moreover.com/click/here.pl%3fz2512215026%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989281&HITNO=0&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989281&THISHREF=http://c.moreover.com/click/here.pl%3fz2512215026%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comVirginian Pilot: US FDA advisory panel back approval of Recordati's Carbaglu and new use for Actelion's Zavescahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912848&HITNO=1&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912848&THISHREF=http://c.moreover.com/click/here.pl%3fz2470402252%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912848&HITNO=1&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912848&THISHREF=http://c.moreover.com/click/here.pl%3fz2470402252%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Letter: FDA panel OKs Recordati's Carbagluhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3909793&HITNO=2&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3909793&THISHREF=http://c.moreover.com/click/here.pl%3fz2468579166%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3909793&HITNO=2&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3909793&THISHREF=http://c.moreover.com/click/here.pl%3fz2468579166%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFierceBiotech: U.S. Panel Urges Approval Drug for N Acetyl Glutamate Synthetase (NAGS) Deficiencyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3909231&HITNO=3&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3909231&THISHREF=http://c.moreover.com/click/here.pl%3fz2468286498%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3909231&HITNO=3&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3909231&THISHREF=http://c.moreover.com/click/here.pl%3fz2468286498%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedscape: U.S. Panel Urges Approval Drug for N Acetyl Glutamate Synthetase (NAGS) Deficiencyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3909174&HITNO=4&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3909174&THISHREF=http://c.moreover.com/click/here.pl%3fz2468267402%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3909174&HITNO=4&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3909174&THISHREF=http://c.moreover.com/click/here.pl%3fz2468267402%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAbstracts in Hematology and Oncology: FDA panel questions Recordati drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3896244&HITNO=5&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3896244&THISHREF=http://c.moreover.com/click/here.pl%3fz2461694053%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3896244&HITNO=5&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3896244&THISHREF=http://c.moreover.com/click/here.pl%3fz2461694053%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFierceBiotech: U.S. FDA staff cite limits of Recordati's datahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890744&HITNO=6&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890744&THISHREF=http://c.moreover.com/click/here.pl%3fz2459356977%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890744&HITNO=6&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890744&THISHREF=http://c.moreover.com/click/here.pl%3fz2459356977%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters Health: UPDATE 2-U.S. FDA staff question study on blood drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888638&HITNO=7&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888638&THISHREF=http://c.moreover.com/click/here.pl%3fz2458472410%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888638&HITNO=7&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=NAGS&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888638&THISHREF=http://c.moreover.com/click/here.pl%3fz2458472410%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: